IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,980 | -26.9% | 1,534 | +13.1% | 0.00% | 0.0% |
Q2 2023 | $9,546 | -36.7% | 1,356 | -45.1% | 0.00% | -50.0% |
Q1 2023 | $15,092 | -26.4% | 2,470 | -23.0% | 0.00% | -33.3% |
Q4 2022 | $20,493 | +127.7% | 3,207 | +228.9% | 0.00% | +50.0% |
Q3 2022 | $9,000 | -18.2% | 975 | -4.4% | 0.00% | 0.0% |
Q2 2022 | $11,000 | -38.9% | 1,020 | -8.0% | 0.00% | -33.3% |
Q1 2022 | $18,000 | -14.3% | 1,109 | -1.4% | 0.00% | 0.0% |
Q4 2021 | $21,000 | +950.0% | 1,125 | +1462.5% | 0.00% | +200.0% |
Q3 2021 | $2,000 | -33.3% | 72 | -40.0% | 0.00% | 0.0% |
Q2 2021 | $3,000 | – | 120 | – | 0.00% | – |
Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q2 2020 | $27,000 | +92.9% | 1,000 | +100.0% | 0.01% | +60.0% |
Q4 2019 | $14,000 | +100.0% | 500 | -33.3% | 0.01% | +66.7% |
Q1 2019 | $7,000 | – | 750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |